ChromaDex(CDXC) - 2023 Q3 - Quarterly Report

Table of Contents General Risks: We have a history of operating losses, may need additional financing to meet our future long-term capital requirements and may be unable to raise suf icient capital on favorable terms or at all. Table of Contents Global, market and economic conditions may negatively impact our business, financial condition and share price. As a consumer-focused company, we expect to generate a significant percentage of our future revenue from sales of our Tru Niagen® product. As a result, th ...